Bio-Techne (TECH) Change in Accured Expenses (2009 - 2026)

Bio-Techne's Change in Accured Expenses history runs 18 years deep, the most recent figure standing at $5.2 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 214.0% year-over-year to $5.2 million in Q1 2026; TTM through Mar 2026 was $13.1 million, a 171.72% increase from a year earlier, with the FY2025 full-year figure at $15.4 million, up 22.11% from the prior year.
• Change in Accured Expenses eased to $5.2 million in Q1 2026 per TECH's latest filing, from $14.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $27.6 million in Q1 2023 and bottomed at -$28.4 million in Q3 2022.
• The 5-year median for Change in Accured Expenses is $2.2 million (2022), against an average of $497058.8.
• Across the five-year window, Change in Accured Expenses tumbled 1131.44% in 2022 and jumped 1136.26% in 2023, its largest moves.
• Year by year, Change in Accured Expenses stood at -$4.9 million in 2022, then soared by 67.18% to -$1.6 million in 2023, then soared by 1018.82% to $14.8 million in 2024, then slipped by 5.4% to $14.0 million in 2025, then plunged by 63.17% to $5.2 million in 2026.
• Per Business Quant, the three latest TECH Change in Accured Expenses figures stand at $5.2 million (Q1 2026), $14.0 million (Q4 2025), and -$22.1 million (Q3 2025).